Hsa-miR-194-5p and Hsa-miR-195-5p Are Down-regulated Expressed in High Dysplasia HPV-positive Pap Smear Samples Compared to Normal Cytology HPV-positive Pap smear Samples

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2024 Feb 11

PMID 38342922

Authors

Ali Dehghani

Fardin Khajepour

Mohammad Dehghani

Ehsan Razmara

Mohammadreza Zangouey

Maryam Fekri Soofi Abadi

Reza Bahram Abadi Nezhad

Shahriar Dabiri

Masoud Garshasbi

Affiliations

Soon will be listed here.

Abstract

Background: The human papillomavirus (HPV) infection may affect the miRNA expression pattern during cervical cancer (CC) development. To demonstrate the association between high-risk HPVs and the development of cervix dysplasia, we examined the expression patterns of hsa-miR-194-5p and hsa-miR-195-5p in Pap smear samples from southeast Iranian women. We compared samples that were HPV-positive but showed no abnormality in the cytological examination to samples that were HPV-positive and had severe dysplasia.

Methods: Pap smear samples were obtained from 60 HPV-positive (HPV-16/18) patients with histologically confirmed severe dysplasia (cervical intra-epithelial neoplasia (CIN 3) or carcinoma in situ) and the normal cytology group. The expression of hsa-miR-194-5p and hsa-miR-195-5p was analyzed by real-time quantitative PCR, using specific stem-loop primers and U6 snRNA as the internal reference gene. Clinicopathological features were associated with miRNA expression levels. Furthermore, functional enrichment analysis was conducted using in silico tools. The Kaplan-Meier survival method was also obtained to discriminate survival-significant candidate miRNAs in CC, and receiver operating characteristic (ROC) curves were constructed to assess the diagnostic value.

Results: Compared to HPV-positive cytologically normal Pap smear samples, hsa-miR-194-5p and hsa-miR-195-5p relative expression decreased significantly in HPV-positive patients with a severe dysplasia Pap smear. Kaplan-Meier analysis indicated a significant association between the miR-194 decrease and poor CC survival. In essence, ROC curve analysis showed that miR-194-5p and miR-195-5p could serve as valuable markers for the development of cervix dysplasia in individuals who are positive for high-risk HPVs.

Conclusions: This study revealed that hsa-miR-194-5p and hsa-miR-195-5p may possess tumor suppressor capabilities in the context of cervical dysplasia progression. However, it remains uncertain whether these microRNAs are implicated in the transition of patients with high dysplasia to cervical cancer. We also showed the potential capability of candidate miRNAs as novel diagnostic biomarkers related to cervical dysplasia progression.

References

Li Y, Li C, Li D, Yang L, Jin J, Zhang B . lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway. Onco Targets Ther. 2019; 12:2649-2660. PMC: 6462170. DOI: 10.2147/OTT.S188054. View

Chai L, Kang X, Sun Z, Zeng M, Yu S, Ding Y . MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells. Cancer Manag Res. 2018; 10:989-1003. PMC: 5937487. DOI: 10.2147/CMAR.S163335. View

Hoelzle C, Arnoult S, Borem C, Ottone M, de Magalhaes K, da Silva I . MicroRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection. Microrna. 2021; 10(2):139-145. DOI: 10.2174/2211536610666210604123534. View

Wang B, Shen Z, Gao Z, Zhao G, Wang C, Yang Y . MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle. 2015; 14(7):1046-58. PMC: 4615039. DOI: 10.1080/15384101.2015.1007767. View

Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R . miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology. 2010; 52(6):2148-57. PMC: 3076553. DOI: 10.1002/hep.23915. View

Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J . The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019; 18(1):4. PMC: 6325825. DOI: 10.1186/s12943-018-0933-7. View

Vlachos I, Zagganas K, Paraskevopoulou M, Georgakilas G, Karagkouni D, Vergoulis T . DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015; 43(W1):W460-6. PMC: 4489228. DOI: 10.1093/nar/gkv403. View

Wentzensen N, Walker J, Gold M, Smith K, Zuna R, Mathews C . Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2014; 33(1):83-9. PMC: 4268255. DOI: 10.1200/JCO.2014.55.9948. View

Azimi T, Paryan M, Mondanizadeh M, Sarmadian H, Zamani A . Pap Smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer. Asian Pac J Cancer Prev. 2021; 22(4):1271-1277. PMC: 8325111. DOI: 10.31557/APJCP.2021.22.4.1271. View

10.

Hanna J, Hossain G, Kocerha J . The Potential for microRNA Therapeutics and Clinical Research. Front Genet. 2019; 10:478. PMC: 6532434. DOI: 10.3389/fgene.2019.00478. View

11.

Zhang S, Xu H, Zhang L, Qiao Y . Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2021; 32(6):720-728. PMC: 7797226. DOI: 10.21147/j.issn.1000-9604.2020.06.05. View

12.

Liu X, Zhou Y, Ning Y, Gu H, Tong Y, Wang N . MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1. Onco Targets Ther. 2020; 13:931-944. PMC: 6996614. DOI: 10.2147/OTT.S227826. View

13.

Wang Y, Xu B, Shen X, Sun L . Diagnostic value of miR-153 and miR-203 in patients with cervical cancer and their correlation with human papillomavirus infection. Am J Transl Res. 2021; 13(8):9736-9742. PMC: 8430153. View

14.

Sun M, Song H, Wang S, Zhang C, Zheng L, Chen F . Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer. J Hematol Oncol. 2017; 10(1):79. PMC: 5372308. DOI: 10.1186/s13045-017-0445-8. View

15.

Das R, Gregory P, Fernandes R, Denis I, Wang Q, Townley S . MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2. Cancer Res. 2016; 77(4):1021-1034. DOI: 10.1158/0008-5472.CAN-16-2529. View

16.

Shen C, Cheng Y, Wang C . LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells. J Drug Target. 2017; 25(7):637-644. DOI: 10.1080/1061186X.2017.1307379. View

17.

Goel M, Khanna P, Kishore J . Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2011; 1(4):274-8. PMC: 3059453. DOI: 10.4103/0974-7788.76794. View

18.

Chen S, Wang L, Yao X, Chen H, Xu C, Tong L . miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinoma. Oncotarget. 2017; 8(38):63986-64000. PMC: 5609979. DOI: 10.18632/oncotarget.19256. View

19.

Causin R, Freitas A, Hidalgo Filho C, Dos Reis R, Reis R, Marques M . A Systematic Review of MicroRNAs Involved in Cervical Cancer Progression. Cells. 2021; 10(3). PMC: 8002658. DOI: 10.3390/cells10030668. View

20.

Nagy A, Munkacsy G, Gyorffy B . Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021; 11(1):6047. PMC: 7961001. DOI: 10.1038/s41598-021-84787-5. View